-
1
TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms
Published 2025-02-01Subjects: “…Triple negative breast cancer (TNBC)…”
Get full text
Article -
2
A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression
Published 2025-04-01“…In this study, bioinformatic analysis and a series of experiments demonstrated that MOCR2 was highly expressed in TNBC and closely associated with poor prognosis, indicating that MOCR2 may be a potential therapeutic target for TNBC. …”
Get full text
Article -
3
Twist-Induced Epithelial-to-Mesenchymal Transition Confers Specific Metabolic and Mitochondrial Alterations
Published 2025-01-01Subjects: Get full text
Article -
4
Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways
Published 2025-02-01“…PurposeLappaol F (LAF), a lignan extracted from Fructus Arctii, has a wide spectrum of anti-tumor effects, including inhibition of TNBC cell growth. However, the pharmacological mechanism of LAF targeting epithelial-mesenchymal transition (EMT) to inhibit Triple-negative breast cancer (TNBC) growth remains poorly understood. …”
Get full text
Article -
5
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration
Published 2025-03-01Subjects: Get full text
Article -
6
Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cells
Published 2025-02-01Subjects: “…TNBC…”
Get full text
Article -
7
Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer
Published 2025-01-01Subjects: “…TNBC…”
Get full text
Article -
8
-
9
Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach
Published 2025-01-01Subjects: “…TNBC…”
Get full text
Article -
10
The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
Published 2025-02-01Subjects: Get full text
Article -
11
LURAP1L-AS1 long noncoding RNA promotes breast cancer progression and associates with poor prognosis
Published 2025-06-01Subjects: Get full text
Article -
12
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
Published 2024-10-01Subjects: Get full text
Article -
13
-
14
-
15
-
16
Clinical Characteristics in Patients with Triple Negative Breast Cancer
Published 2017-01-01“…The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis. …”
Get full text
Article -
17
Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Published 2025-01-01“…The therapeutic effects of PA may vary across different subtypes of TNBC such as TNBC-BL1, TNBC-Metaplastic, and TNBC-BL2. …”
Get full text
Article -
18
Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
Published 2020-01-01“…Triple negative breast cancer (TNBC) is associated with aggressive tumour phenotype and early tumour relapse following diagnosis. …”
Get full text
Article -
19
SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
Published 2025-01-01“…Results We found that high SHP2 expression was associated with a poor prognosis in patients with TNBC. The migratory and invasive abilities of TNBC cells in vitro, as well as the metastatic potential of TNBC in mouse xenograft models, were reduced after SHP2 depletion. …”
Get full text
Article -
20
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Published 2025-01-01“…We profiled circulating immune cells in stage I–III and stage IV triple-negative breast cancer (TNBC) patients and healthy donors (HDs). Metastatic TNBC (mTNBC) patients had reduced T cells, dendritic cells, and differentiated B cells compared to non-metastatic TNBC patients and HDs, partly linked to prior chemotherapy. …”
Get full text
Article